SEC Comment Letter for Jaguar Health, Inc. (JAGX) (CIK 0001585608) (JAGX) — Apr 10, 2020
Jaguar Health, Inc. (JAGX) (CIK 0001585608)
Date: April 10, 2020 · CIK: 0001585608 · Accession: 0000000000-20-003131
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-237587
Letter
April 10, 2020 Lisa Conte Chief Executive Officer and President Jaguar Health, Inc. 201 Mission Street, Suite 2375 San Francisco, California 94105 Re:Jaguar Health, Inc. Registration Statement on Form S-1 Filed April 6, 2020 File No. 333-237587 Dear Ms. Conte: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Courtney Lindsay at (202) 551-7237 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
April 10, 2020
Lisa Conte
Chief Executive Officer and President
Jaguar Health, Inc.
201 Mission Street, Suite 2375
San Francisco, California 94105
Re:Jaguar Health, Inc.
Registration Statement on Form S-1
Filed April 6, 2020
File No. 333-237587
Dear Ms. Conte:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Courtney Lindsay at (202) 551-7237 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences